【24h】

Biotechnology news

机译:生物技术新闻

获取原文
获取原文并翻译 | 示例
       

摘要

Genentech Inc. (South San Francisco, CA) has been ordered to pay City of Hope National Medical Center (COM) (Duarte, CA) about 300 million dollar in additional royalties for breach of a 1976 agreement between the two groups. The jury will decide nextweek what, if any, punitive damages to award COM. The dispute centers on patents on a technique for producing human'insulin. COM developed it and Genentech acquired the patents in exchange for royalties. In its suit, COH said that Genentech owed it royalties from deals Genentech made to license the patents to other companies and that it tried to hide those deals. This is the second time this has gone to trial. The first trial ended in a hung jury. Genentech said it will not address the issue of appealuntil all proceedings in the trial are conducted.
机译:Genentech Inc.(加利福尼亚州南旧金山)已被勒令向希望之城国家医疗中心(COM)(加利福尼亚州Duarte)支付约3亿美元的额外特许权使用费,原因是这两个集团之间在1976年达成了一项协议。陪审团将在下周决定判处COM何种惩罚性赔偿。争议的焦点在于生产人胰岛素的技术的专利。 COM开发了它,而Genentech则获得了专利权以换取特许权使用费。 COH在诉讼中说,Genentech欠Genentech许可将专利许可给其他公司的交易的特许权使用费,并试图隐藏这些交易。这是第二次对此进行审判。第一次审判以陪审团告终。基因泰克公司表示,直到审判的所有程序都进行完毕,它才会解决上诉问题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号